ClinVar Miner

Submissions for variant NM_000083.3(CLCN1):c.892G>A (p.Ala298Thr)

gnomAD frequency: 0.00002  dbSNP: rs764100025
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000638241 SCV000759727 pathogenic Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form 2022-12-31 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects CLCN1 function (PMID: 28706458). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN1 protein function. ClinVar contains an entry for this variant (Variation ID: 531747). This missense change has been observed in individuals with autosomal dominant myotonia congenita (MC) (PMID: 21045501, 27118449, 27415035, 28706458). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs764100025, gnomAD 0.01%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 298 of the CLCN1 protein (p.Ala298Thr).
Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota RCV000761298 SCV000891273 likely pathogenic Congenital myotonia, autosomal dominant form 2016-06-20 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000991830 SCV001143604 pathogenic not provided 2021-08-18 criteria provided, single submitter clinical testing The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been reported as autosomal dominant myotonia congenita (PMID: 27415035, 21045501), and has also been reported as autosomal recessive myotonia congenita (PMID: 27118449). This variant segregates with disease in at least one family. Assessment of experimental evidence suggests this variant results in abnormal protein function. Study shows this variant results in altered channel properties (PMID:28706458).
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000761298 SCV005381410 pathogenic Congenital myotonia, autosomal dominant form 2024-08-05 criteria provided, single submitter clinical testing Variant summary: CLCN1 c.892G>A (p.Ala298Thr) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251390 control chromosomes. c.892G>A has been reported in the literature in in the heterozygous and compound heterozygous states in multiple individuals affected with autosomal dominant and autosomal recessive myotonia congenita and segregated with disease in at least two families (e.g. Yang_2017, Chin_2017, Sasaki_2020, Meng_2016). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence that this variant results in reduced chloride current density and altered channel gating compared to wildtype in vitro (e.g. Chin_2017). The following publications have been ascertained in the context of this evaluation (PMID: 28706458, 27118449, 32660787, 27415035). ClinVar contains an entry for this variant (Variation ID: 531747). Based on the evidence outlined above, the variant was classified as pathogenic.
Mayo Clinic Laboratories, Mayo Clinic RCV000991830 SCV005413811 pathogenic not provided 2024-04-08 criteria provided, single submitter clinical testing PP1_strong, PP3, PM1, PS3_moderate, PS4_moderate
Juno Genomics, Hangzhou Juno Genomics, Inc RCV000638241 SCV005416428 pathogenic Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form criteria provided, single submitter clinical testing PM2_Supporting+PS4_Moderate+PP1_Strong+PP4+PP3_Moderate
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences RCV002267619 SCV002549781 pathogenic Congenital myotonia, autosomal recessive form 2022-04-06 no assertion criteria provided research
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences RCV000761298 SCV002549790 pathogenic Congenital myotonia, autosomal dominant form 2022-04-06 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.